A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1997
11/19/1997	EP0807441A2 Improvements in or relating to contrast agents
11/19/1997	EP0806969A2 Liposomes containing contrast media for blood pool imaging
11/19/1997	EP0806968A2 Diagnostic imaging contrast agents with extended blood retention
11/19/1997	EP0806967A1 Gene transfer for treating a connective tissue of a mammalian host
11/19/1997	EP0341252B1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/18/1997	US5688834 Catalysts which stabilize hydrohalocarbon blowing agent in polyurethane foam formulations
11/18/1997	US5688768 Recombinant thrombin receptor and related pharmaceuticals
11/18/1997	US5688490 Mucoadhesive compositions for increasing the ultrasonic image contrast of the digestive tract
11/18/1997	US5688488 Composition and method for tumor imaging
11/18/1997	US5688486 Use of fullerenes in diagnostic and/or therapeutic agents
11/13/1997	WO1997041856A1 ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO)
11/13/1997	WO1997041854A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
11/12/1997	EP0806670A2 Use of an anticoagulant as a diagnostic agent
11/12/1997	EP0805983A1 Process and compounds for the magnetorelaxometric detection of analytes and use thereof
11/12/1997	EP0805815A1 Bismuth compounds
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/11/1997	US5686492 Disubstituted p-fluorobenzenesulfonamides
11/11/1997	US5686416 Bradykinin analogues; nona-, deca- and polypeptides
11/11/1997	US5686255 Determining amount of modified dopamine d4 receptor having adenosylated methionine
11/11/1997	US5686245 Methods for screening for agents which modulate telomere length
11/11/1997	US5686061 Particulate contrast media derived from non-ionic water soluble contrast agents for CT enhancement of hepatic tumors
11/11/1997	US5686060 Stable microbubble suspensions comprising saturated phospholipids for ultrasound echography
11/11/1997	US5686059 Cartilage matrix protein and methods for use
11/11/1997	US5685310 Suspended ultra-sound microbubble imaging
11/06/1997	WO1997040859A1 Bridge-substituted tropanes and uses
11/06/1997	WO1997040858A1 Novel dispersible lipid blends and uses therefor
11/06/1997	WO1997040856A1 Diagnostic composition
11/05/1997	EP0804944A2 A method of providing a gas composition in a biological tissue or fluid in vivo
11/05/1997	EP0804932A2 Contrast media for diagnostic imaging comprising gas filled microspeures
11/05/1997	EP0804439A1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles
11/05/1997	EP0804251A1 Blood-pool imaging compositions use and method
11/05/1997	EP0804250A1 Use of methylene malonic diester derivatives in the production of gas-containing microparticles for use in ultrasound diagnostics, and agents containing these particles
11/05/1997	EP0804222A1 Accessory factor function for interferon gamma and its receptor
11/05/1997	EP0804214A1 Growth differentiation factor-6
11/05/1997	EP0804162A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation
11/05/1997	EP0804161A1 Continuous method of grinding pharmaceutical substances
11/05/1997	EP0670041A4 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds.
11/05/1997	EP0487718B1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety
11/05/1997	CN1164238A Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
11/05/1997	CN1164225A Iodinated X-ray-contrast media
11/04/1997	US5684135 Antitumor agents
11/04/1997	US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
11/04/1997	US5683907 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
11/04/1997	US5683888 Modified bioluminescent proteins and their use
11/04/1997	US5683723 Nanoparticles based on a polyoxyethelene and polyactic acid block copolymer
11/04/1997	US5683701 Peptide fragments of HIV
10/1997
10/30/1997	WO1997040142A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040055A1 Fluorescent chelates as visual tissue specific imaging agents
10/30/1997	WO1997039735A1 Improved masking of liposomes from res recognition
10/30/1997	CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	CA2250921A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	CA2250529A1 Improved masking of liposomes from res recognition
10/29/1997	EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997	EP0802788A1 Novel therapeutic delivery systems
10/29/1997	EP0802767A1 Inhalable contrast agent
10/28/1997	US5681960 Immunoassay
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681544 Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them
10/28/1997	US5681543 Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
10/28/1997	US5681542 Compositions comprising a biocompatible gas and a polymer for magnetic resonance imaging
10/23/1997	WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	WO1997031657A3 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors
10/23/1997	WO1997030735A3 A process for the purification of opacifying contrast agents
10/23/1997	WO1997026921A3 Contrast media
10/23/1997	WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997	WO1997026016A3 Gas bubble suspensions and their application as an ultrasound contrast medium
10/23/1997	WO1997025068A3 Mesothelin antigen and methods and kits for targeting it
10/23/1997	WO1997013490A3 Contrasting agents for near infrared diagnosis containing colloidal systems loaded with polymethine dyes
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/22/1997	EP0700393B1 Macrocyclic metal complexes containing fluorine
10/22/1997	EP0679093B1 Methods of delivering agents to target cells
10/21/1997	US5679810 Amide or ester linkages; complexes paramagnetic metal ions; diagnostic imaging
10/21/1997	US5679394 Adjunct administration of particulate therapeutic or diagnostic agent and dwell-time enhancing agent
10/21/1997	US5679323 Arabinogalactan modified to incorporate a diagnostic label
10/21/1997	US5679322 Iodinated borane cage molecules as X-ray contrast media
10/21/1997	US5679320 Fibrin binding domain polypeptides and uses and methods of producing same
10/16/1997	WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997	WO1997027462A3 Use of peptides in tracing disease and developing vaccines
10/16/1997	CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/15/1997	EP0800831A1 Diagnostic marker
10/15/1997	EP0800545A1 Targeted magnetically labeled molecular marker systems for the nmr imaging
10/15/1997	EP0800404A2 Oral gastrointestinal diagnostic x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants
10/15/1997	EP0721312A4 Use of photodynamic therapy to treat prostatic tissue
10/15/1997	EP0603403B1 Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound
10/15/1997	EP0583401B1 Porous inorganic ultrasound contrast agents
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/15/1997	CN1161863A Medical supersonic couplant
10/14/1997	US5677445 Polycyclic complexing agents
10/14/1997	US5677427 Chimeric antibody for detection and therapy of infectious and inflammatory lesions
10/14/1997	US5677199 Fluorescent marker components and fluorescent probes
10/14/1997	US5676928 Autoclaved diagnostic composition
10/14/1997	US5676927 Magnetic resonance imaging
10/14/1997	US5676925 Using polyester or acrylate polymers
10/14/1997	US5676924 In vivo assay to determine cancer treatment effectiveness
10/14/1997	US5676923 Soluble, stable, organ-specific nuclear magnetic resonance contrast agent
10/09/1997	WO1997037239A1 Enhancement of nmr and mri in the presence of hyperpolarized noble gases
10/09/1997	WO1997037178A1 High volume hyperpolarizer for spin-polarized noble gas

1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 354